Isolated post SARS‑CoV‑2 diplopia Thiago Gonçalves dos Santos Martins Letter to the Editors 18 July 2020 Pages: 391 - 391
A systematic review of neurological symptoms and complications of COVID-19 Xiangliang ChenSarah LaurentClemens Warnke Review Open access 20 July 2020 Pages: 392 - 402
Impact of the COVID-19 outbreak on acute stroke care L. A. RinkelJ. C. M. PrickJ. M. Coutinho Original Communication Open access 20 July 2020 Pages: 403 - 408
COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? Luigi Ferini-StrambiMaria Salsone Review 21 July 2020 Pages: 409 - 419
Amyotrophic lateral sclerosis patients’ and caregivers' distress and loneliness during COVID-19 lockdown Monica ConsonniAlessandra TelescaGiuseppe Lauria Letter to the Editors 21 July 2020 Pages: 420 - 423
Comment on “Stroke in patients with SARS‑CoV‑2 infection: case series” from a London hospital experience Anan ShtayaSarah TrippierLiqun Zhang Letter to the Editors 25 July 2020 Pages: 424 - 430
Dissociation of caloric and head impulse tests: a marker of Meniere's disease I. P. HanniganM. S. WelgampolaShaun R. D. Watson Review 20 June 2019 Pages: 431 - 439
Steroids use and survival in patients with glioblastoma multiforme: a pooled analysis Fausto PetrelliAgostina De StefaniFrancesca Trevisan Review 30 January 2020 Pages: 440 - 447
The PRIAMO study: age- and sex-related relationship between prodromal constipation and disease phenotype in early Parkinson’s disease Marina PicilloRaffaele Palladinoon behalf of the PRIAMO study group Original Communication Open access 18 August 2020 Pages: 448 - 454
Specific B- and T-cell populations are associated with cognition in patients with epilepsy and antibody positive and negative suspected limbic encephalitis Christoph HelmstaedterNiels HansenJuri-Alexander Witt Original Communication Open access 20 August 2020 Pages: 455 - 466
Associated co-morbidities in a retrospective cohort of orthostatic tremor Louise Bicart-SéeJean-Luc ThibaultNathalie Kubis Original Communication 20 August 2020 Pages: 467 - 473
Age is negatively associated with upper limb recovery after conventional but not robotic rehabilitation in patients with stroke: a secondary analysis of a randomized-controlled trial Francesca CecchiMarco GermanottaIrene Aprile Original Communication 25 August 2020 Pages: 474 - 483
Dyslexia and cognitive impairment in adult patients with myotonic dystrophy type 1: a clinical prospective analysis K. GutschmidtS. WenningerB. Schoser Original Communication Open access 26 August 2020 Pages: 484 - 492
Seizures at the onset of aneurysmal SAH: epiphenomenon or valuable predictor? Marvin Darkwah OppongMarcela Jara BastiasRamazan Jabbarli Original Communication Open access 27 August 2020 Pages: 493 - 501
Brainstem encephalitis in neuroborreliosis: typical clinical course and distinct MRI findings Thomas PfefferkornJoachim RötherHendrik Janssen Original Communication 28 August 2020 Pages: 502 - 505
Common genetic variants in PRRC2A are associated with both neuromyelitis optica spectrum disorder and multiple sclerosis in Han Chinese population Juan ZhangMei-Jiao ChenZhi-Ying Wu Original Communication 29 August 2020 Pages: 506 - 515
One-year survival of patients with high-grade glioma discharged alive from the intensive care unit Maxens DecavèleNicolas GatulleAlexandre Demoule Original Communication 29 August 2020 Pages: 516 - 525
Vestibular impairment in Charcot–Marie–Tooth disease Gülden AkdalKoray KoçoğluHatice Karasoy Original Communication 30 August 2020 Pages: 526 - 531
Microvascular decompression for trigeminal neuralgia in the elderly: efficacy and safety Tobias GreveJoerg-Christian TonnJan-Hinnerk Mehrkens Original Communication Open access 30 August 2020 Pages: 532 - 540
Impact of pre-stroke dependency on outcome after endovascular therapy in acute ischemic stroke Lisa OeschMarcel ArnoldHakan Sarikaya Original Communication Open access 31 August 2020 Pages: 541 - 548
Vascular risk factors, white matter lesions and cognitive impairment in Parkinson’s disease: the PACOS longitudinal study Alessandra NicolettiAntonina LucaRoberto Monastero Original Communication Open access 31 August 2020 Pages: 549 - 558
Comorbidities contribute substantially to the severity of common multiple sclerosis symptoms Lara Marie Pangan LoBruce V. TaylorIngrid van der Mei Original Communication 02 September 2020 Pages: 559 - 568
Estimating the relative contribution of comorbidities in predicting health-related quality of life of people with multiple sclerosis Lara Marie Pangan LoBruce V. TaylorIngrid van der Mei Original Communication 02 September 2020 Pages: 569 - 581
Parkinson’s disease laterality: a 11C-PE2I PET imaging study Andreas-Antonios RoussakisZhou ZengTRANSEURO consortium Original Communication Open access 02 September 2020 Pages: 582 - 589
Feasibility and initial validation of ‘HD-Mobile’, a smartphone application for remote self-administration of performance-based cognitive measures in Huntington’s disease Brendan McLarenSophie C. AndrewsJulie C. Stout Original Communication 03 September 2020 Pages: 590 - 601
Change and onset-type differences in the prevalence of comorbidities in people with multiple sclerosis Lara Marie Pangan LoBruce V. TaylorIngrid van der Mei Original Communication 03 September 2020 Pages: 602 - 612
Does pallidal neuromodulation influence cognitive decline in Huntington’s disease? Emily SanreyValérie MacioceGaetan Poulen Original Communication 04 September 2020 Pages: 613 - 622
Inter-hospital transfer for mechanical thrombectomy within the supraregional stroke network NEVAS Katharina FeilJan RémiLars Kellert Original Communication Open access 05 September 2020 Pages: 623 - 631
Hemorrhagic reversible cerebral vasoconstriction syndrome: A retrospective observational study Smit D. PatelKaran TopiwalaRobert M. Starke Original Communication 07 September 2020 Pages: 632 - 639
Deep geno- and phenotyping in two consanguineous families with CMT2 reveals HADHA as an unusual disease-causing gene and an intronic variant in GDAP1 as an unusual mutation Marzieh KhaniHanieh TaheriElahe Elahi Original Communication 08 September 2020 Pages: 640 - 650
Intrathecal treatment trial of rituximab in progressive MS: results after a 2-year extension Joakim BergmanJoachim BurmanAnders Svenningsson Original Communication Open access 08 September 2020 Pages: 651 - 657
Dopaminergic therapy and prefrontal activation during walking in individuals with Parkinson’s disease: does the levodopa overdose hypothesis extend to gait? Moria DaganTalia HermanJeffrey M. Hausdorff Original Communication 09 September 2020 Pages: 658 - 668
SMILE: a predictive model for Scoring the severity of relapses in MultIple scLErosis F. LejeuneA. ChattonLaure Michel Original Communication 09 September 2020 Pages: 669 - 679
Polyradiculoneuropathy induced by immune checkpoint inhibitors: a case series and review of the literature Kensuke OkadaMorinobu SekiShigeaki Suzuki Original Communication 09 September 2020 Pages: 680 - 688
Clinical characteristics in unilateral vestibular atelectasis Morgane MarcCharlotte HautefortMichael Eliezer Original Communication 09 September 2020 Pages: 689 - 700
Deep brain stimulation of the internal globus pallidus does not affect the limbic circuit in patients with Parkinson’s disease: a PET study Xavier Palard-NovelloSophie DrapierFlorence Le Jeune Original Communication 10 September 2020 Pages: 701 - 706
Dangerous sweets: severe hypokalemia with rhabdomyolysis and tetraparesis from chronic consumption of licorice Matthias WittstockAllessandro MeleAlexander Storch Letter to the Editors Open access 19 December 2020 Pages: 707 - 708
Anti-glycin-receptor antibody related stiff-person syndrome under treatment with an immune checkpoint inhibitor Nils SchröterCornelius WeillerCornelius F. Waller Letter to the Editors Open access 24 December 2020 Pages: 709 - 711
Unexpected ketamine effect in a patient with cervical dystonia Cecilia NenciniVincenzo De SantisMaurizio Fusari Letter to the Editors 02 January 2021 Pages: 712 - 713
NMDAR antibody encephalitis overlapping with CLIPPERS syndrome in a psoriasis patient on adalimumab Talora MartinSean DukeHesham Abboud Letter to the Editors 02 January 2021 Pages: 714 - 716
Neutrophil-to-lymphocyte ratio: a marker of neuro-inflammation in multiple sclerosis? Stefano GelibterMarco PisaMassimo Filippi Short Commentary 03 January 2021 Pages: 717 - 723
Towards early disease modification of Parkinson’s disease: a review of lessons learned in the Alzheimer field Marthe SmedingaSirwan K. L. DarweeshEdo Richard Neurological Update Open access 18 August 2020 Pages: 724 - 733
The use of calcitonin gene related peptide monoclonal antibodies in the difficult to treat migraine population T. CosslettC. Mitchell Journal Club 13 January 2021 Pages: 734 - 736
Liliana Lubińska (1904–1990) Karol WiśniewskiJoanna Wojtkiewicz Pioneers in Neurology Open access 16 March 2020 Pages: 737 - 738
RETRACTED ARTICLE: Acute necrotizing myelitis and acute motor axonal neuropathy in a COVID-19 patient Catalina MaideniucAnza B. Memon Letter to the Editors 09 August 2020 Pages: 739 - 739
Correction to: Utility of the Parkinson’s disease-Cognitive Rating Scale for the screening of global cognitive status in Huntington’s disease Saul Martinez-HortaAndrea Horta-BarbaCognitive Phenotype Working Group of the European Huntington’s Disease Network Correction 05 January 2021 Pages: 740 - 740
Correction to: Refractory anti‑NMDAR encephalitis successfully treated with bortezomib and associated movements disorders controlled with tramadol: a case report with literature review Serena Marita LazzarinMarco VabanesiFabio Minicucci Correction 08 January 2021 Pages: 741 - 742
